Skip navigation
Agenda

Innovative Contracting and Pricing Strategies in an Ultra-Competitive and Evolving Healthcare System

January 24-25, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE Wednesday, January 24, 2018

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Edward McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.

Industry Pulse on the Evolving Healthcare Environment Impacting the Reimbursement
and Contracting Landscape

8:45

OPENING KEYNOTE ADDRESS Hear the Latest Healthcare Updates and the Implications for Contracting and Reimbursement Strategies

Robert Goldberg, PhD
Vice President and Co-Founder
Center for Medicine in the Public Interest

9:30

NAVIGATING NEW TERRAINS Align New Technologies and New Treatment Paradigms Within Existing Reimbursement Systems and Utilize AI Technologies to Enhance Efficiency

Everett Crosland
Executive Director, Market Access and Reimbursement
Pear Therapeutics

Todd C. Lord
PharmD, Vice President
Magellan Method, a division of Magellan Rx Management

10:15

Networking and Refreshment Break

10:45

Examine the Rise of IDNs and Benefits of Partnering with IDNs in the
Era of Risk-Sharing

Jerry Taglianetti
Director of U.S. Payer and Channel Access
Pfizer Inc

11:30

SPECIALTY SNAPSHOT Overcome Key Challenges Facing the Specialty Marketplace

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics Inc

12:15

Networking Luncheon

1:30

Explore Outcomes-Based Contracting to Facilitate Enhanced Access
for Biosimilars

Omar Ali
Visiting Lecturer, Value Based Pricing and Innovative Contracting
University of Portsmouth;
External Advisor, NICE

2:30

Networking and Refreshment Break

Explore Innovative Contracting and Pricing Strategies to Optimize Reimbursement

3:00

INDUSTRY EXCHANGE Garner Best Practices to Develop Innovative Contracting and
Implement Effective Pricing Strategies

CONVERSATION CONTRIBUTORS:

Samir Mistry, PharmD
Vice President, Rebates and Pricing Strategy
Abarca Health

Santosh Panda
Director, Government Contracts and Pricing
Alvogen Inc.

4:00

TABLE TALKS Discuss Company-Specific Challenges

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, January 25, 2018

7:30

Continental Breakfast

8:30

Chairman’s Review of Day One

Edward McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.

Industry Pulse on the Evolving Healthcare Environment Impacting the Reimbursement
and Contracting Landscape

8:45

STAKEHOLDER PANEL Contracting and Pricing Strategies to Achieve Positive Outcomes
for All Stakeholders

MODERATOR:

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

PANELISTS:

Marc Claussen
Director, Market Access
Chiesi USA, Inc.

Kesslyn Smith
Consultant, Patient Access and Reimbursement
formerly with Sandoz, Otsuka and Sanofi

Todd C. Lord
PharmD, Vice President
Magellan Method, a division of Magellan Rx Management

9:45

PAYER SPOTLIGHT Shine Light on Value-Based Contracting

Samir Mistry, PharmD
Vice President, Rebates and Pricing Strategy
Abarca Health

10:30

Networking and Refreshment Break

11:15

IN-DEPTH CASE STUDY Outcomes-Based Contracting — What Happens After the Signature?

Omar Ali
Visiting Lecturer, Value Based Pricing and Innovative Contracting
University of Portsmouth;
External Advisor, NICE

12:00

Networking Luncheon

1:00 – 3:00

Choose Between Two In-Conference Workshops (A-B)

A Commercial Pricing and Contracting Master Class

Manufacturers face the challenge of understanding the complex commercial pricing and contracting environment. These challenges are heighted with new policies and market trends surrounding patient access, Medicaid reimbursement for fee-for-service, ACO and IDN contracting, Medicare Part B and Part D, 340B and risk-share agreements. This workshop serves as an opportunity for new and established professionals to stay up-to-date on the latest changes in the contracting and pricing arena.

I. Commercial Contracting Structures and Strategies — Managed Care, GPOs, IDNs and Specialty Pharmacies

II. Contract Life Cycle and Best Practices to Manage and Maintain

III. Commercial Pricing Calculations and Payments

IV. Measure Contract Success and Recognize ROI

WORKSHOP LEADERS:

Jennifer English
Director, Market Access – Pricing, Contracting and Government Program
Insmed Inc.

Stephanie Kupski
Director, Pricing and Contracting
Horizon Pharma Inc.

B Navigate the Complexities of 340B and Its Impact on Pricing and Contracting

The 340B Program is rapidly evolving and greatly impacts reimbursement and contracting by influencing AMP and best price. It is critical for manufacturers to understand this highly complex program to avoid duplicate discounts and diversions, collaborate with covered entities and contract pharmacies, define eligible patients and accurately calculate prices. This workshop explores rules and HRSA guidance, highlighting key components impacting pharmaceutical manufacturers in both government and commercial contracting.

I. Regulatory Updates

II. Self-Disclosure Letter Best Practices to Respond and Resolve

III. Strategies for Pricing Eligibility and Membership Determination

WORKSHOP LEADER:

Jeff Davis
Vice President,
Legislative and Policy Counsel
340B Health

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE Wednesday, January 24, 2018

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Edward McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.

Industry Pulse on the Evolving Healthcare Environment Impacting the Reimbursement
and Contracting Landscape

8:45

OPENING KEYNOTE ADDRESS Hear the Latest Healthcare Updates and the Implications for Contracting and Reimbursement Strategies

Robert Goldberg, PhD
Vice President and Co-Founder
Center for Medicine in the Public Interest

9:30

NAVIGATING NEW TERRAINS Align New Technologies and New Treatment Paradigms Within Existing Reimbursement Systems and Utilize AI Technologies to Enhance Efficiency

Everett Crosland
Executive Director, Market Access and Reimbursement
Pear Therapeutics

Todd C. Lord
PharmD, Vice President
Magellan Method, a division of Magellan Rx Management

10:15

Networking and Refreshment Break

10:45

Examine the Rise of IDNs and Benefits of Partnering with IDNs in the
Era of Risk-Sharing

Jerry Taglianetti
Director of U.S. Payer and Channel Access
Pfizer Inc

11:30

SPECIALTY SNAPSHOT Overcome Key Challenges Facing the Specialty Marketplace

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics Inc

12:15

Networking Luncheon

1:30

Explore Outcomes-Based Contracting to Facilitate Enhanced Access
for Biosimilars

Omar Ali
Visiting Lecturer, Value Based Pricing and Innovative Contracting
University of Portsmouth;
External Advisor, NICE

2:30

Networking and Refreshment Break

Explore Innovative Contracting and Pricing Strategies to Optimize Reimbursement

3:00

INDUSTRY EXCHANGE Garner Best Practices to Develop Innovative Contracting and
Implement Effective Pricing Strategies

CONVERSATION CONTRIBUTORS:

Samir Mistry, PharmD
Vice President, Rebates and Pricing Strategy
Abarca Health

Santosh Panda
Director, Government Contracts and Pricing
Alvogen Inc.

4:00

TABLE TALKS Discuss Company-Specific Challenges

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, January 25, 2018

7:30

Continental Breakfast

8:30

Chairman’s Review of Day One

Edward McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.

Industry Pulse on the Evolving Healthcare Environment Impacting the Reimbursement
and Contracting Landscape

8:45

STAKEHOLDER PANEL Contracting and Pricing Strategies to Achieve Positive Outcomes
for All Stakeholders

MODERATOR:

Donna White
Vice President, Contracts and Compliance
Chiesi USA, Inc.

PANELISTS:

Marc Claussen
Director, Market Access
Chiesi USA, Inc.

Kesslyn Smith
Consultant, Patient Access and Reimbursement
formerly with Sandoz, Otsuka and Sanofi

Todd C. Lord
PharmD, Vice President
Magellan Method, a division of Magellan Rx Management

9:45

PAYER SPOTLIGHT Shine Light on Value-Based Contracting

Samir Mistry, PharmD
Vice President, Rebates and Pricing Strategy
Abarca Health

10:30

Networking and Refreshment Break

11:15

IN-DEPTH CASE STUDY Outcomes-Based Contracting — What Happens After the Signature?

Omar Ali
Visiting Lecturer, Value Based Pricing and Innovative Contracting
University of Portsmouth;
External Advisor, NICE

12:00

Networking Luncheon

1:00 – 3:00

Choose Between Two In-Conference Workshops (A-B)

A Commercial Pricing and Contracting Master Class

Manufacturers face the challenge of understanding the complex commercial pricing and contracting environment. These challenges are heighted with new policies and market trends surrounding patient access, Medicaid reimbursement for fee-for-service, ACO and IDN contracting, Medicare Part B and Part D, 340B and risk-share agreements. This workshop serves as an opportunity for new and established professionals to stay up-to-date on the latest changes in the contracting and pricing arena.

I. Commercial Contracting Structures and Strategies — Managed Care, GPOs, IDNs and Specialty Pharmacies

II. Contract Life Cycle and Best Practices to Manage and Maintain

III. Commercial Pricing Calculations and Payments

IV. Measure Contract Success and Recognize ROI

WORKSHOP LEADERS:

Jennifer English
Director, Market Access – Pricing, Contracting and Government Program
Insmed Inc.

Stephanie Kupski
Director, Pricing and Contracting
Horizon Pharma Inc.

B Navigate the Complexities of 340B and Its Impact on Pricing and Contracting

The 340B Program is rapidly evolving and greatly impacts reimbursement and contracting by influencing AMP and best price. It is critical for manufacturers to understand this highly complex program to avoid duplicate discounts and diversions, collaborate with covered entities and contract pharmacies, define eligible patients and accurately calculate prices. This workshop explores rules and HRSA guidance, highlighting key components impacting pharmaceutical manufacturers in both government and commercial contracting.

I. Regulatory Updates

II. Self-Disclosure Letter Best Practices to Respond and Resolve

III. Strategies for Pricing Eligibility and Membership Determination

WORKSHOP LEADER:

Jeff Davis
Vice President,
Legislative and Policy Counsel
340B Health

3:00

Close of Conference